Full metadata record

DC Field Value Language
dc.contributor.authorJung, SH-
dc.contributor.authorCho, SH-
dc.contributor.authorDang, TH-
dc.contributor.authorLee, JH-
dc.contributor.authorJu, JH-
dc.contributor.authorKim, MK-
dc.contributor.authorLee, SH-
dc.contributor.authorRyu, JC-
dc.contributor.authorKim, Y-
dc.date.accessioned2024-01-21T09:02:58Z-
dc.date.available2024-01-21T09:02:58Z-
dc.date.created2021-09-03-
dc.date.issued2003-05-
dc.identifier.issn0223-5234-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/138623-
dc.description.abstractSophoricoside isolated from Sophora japonica is a glycoside of isoflavonone as an inhibitor of interleukin (IL)-5. To identify structural requirements of this isoflavonone for its inhibitory activity against IL-5, isoflavonones, isoflavanones, and their glycosides were prepared and their inhibitory activity was tested against IL-5. Among them, 5-benzyloxy-3-(4-hydroxyphenyl)chromen-4-one (4b, 87.9% inhibition at 50 muM, IC50 = 15.3 muM) shows the most potent activity, comparable with that of sophoricoside. The important structural requirements of these isoflavonone analogs exhibiting the inhibitory activity against IL-5 were recognized as (1) planarity of chromen-4-one ring, (2) existence of phenolic hydroxyl at 4-position of B ring, and (3) introduction of benzyloxy at 5-position, which may act as a bulky group for occupying hydrophobic pocket in putative binding site. However the glucopyranosyl moiety of sophoricoside is not an essential motif for the activity. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER-
dc.subjectAIRWAY HYPERRESPONSIVENESS-
dc.subjectSOPHORICOSIDE ANALOGS-
dc.subjectMOLECULAR-CLONING-
dc.subjectIL-5-
dc.subjectEOSINOPHILIA-
dc.subjectEXPRESSION-
dc.subjectHYPERREACTIVITY-
dc.subjectRECEPTORS-
dc.subjectBINDING-
dc.subjectLEADS-
dc.titleStructural requirement of isoflavonones for the inhibitory activity of interleukin-5-
dc.typeArticle-
dc.identifier.doi10.1016/S0223-5234(03)00064-3-
dc.description.journalClass1-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.38, no.5, pp.537 - 545-
dc.citation.titleEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.volume38-
dc.citation.number5-
dc.citation.startPage537-
dc.citation.endPage545-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000183501100011-
dc.identifier.scopusid2-s2.0-0037722923-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusAIRWAY HYPERRESPONSIVENESS-
dc.subject.keywordPlusSOPHORICOSIDE ANALOGS-
dc.subject.keywordPlusMOLECULAR-CLONING-
dc.subject.keywordPlusIL-5-
dc.subject.keywordPlusEOSINOPHILIA-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusHYPERREACTIVITY-
dc.subject.keywordPlusRECEPTORS-
dc.subject.keywordPlusBINDING-
dc.subject.keywordPlusLEADS-
dc.subject.keywordAuthorsophoricoside-
dc.subject.keywordAuthorisoflavonones-
dc.subject.keywordAuthorinhibitory activity of interleukin-5-
Appears in Collections:
KIST Article > 2003
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE